Access to Fertility Treatment and Care Act
- Bill Number
- S. 2408
- Origin Chamber
- Senate
- Congress
- 119th Congress, Session 1
- Policy Area
- Health
- Status
- Introduced
- Latest Action
- 2025-07-23: Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
- Last Updated
- 2025-12-05T21:58:55Z
AI-Generated Summary
Purpose
The Access to Fertility Treatment and Care Act (S. 2408) aims to expand access to fertility treatments by requiring coverage under various health insurance plans and government programs. It ensures that individuals with health coverage for pregnancy-related (obstetrical) services also receive support for fertility care, without needing a formal infertility diagnosis, to help people build families.
Key Provisions
- Mandatory Coverage in Private Health Plans:
- Amends the Public Health Service Act (PHSA), Employee Retirement Income Security Act (ERISA), and Internal Revenue Code (IRC) to require group and individual health plans that cover obstetrical services to include fertility treatments.
- Defines fertility treatment broadly to include: preservation of eggs (oocytes), sperm, or embryos; artificial insemination (e.g., intrauterine insemination); assisted reproductive technologies like in vitro fertilization (IVF); genetic testing of embryos; fertility medications; gamete (egg or sperm) donation; and other related services as determined by the Secretary of Health and Human Services.
- Coverage must be provided if deemed appropriate by a healthcare provider and performed at a facility meeting federal standards, regardless of an infertility diagnosis (as defined by the American Society for Reproductive Medicine, a professional group setting medical guidelines).
- Cost-Sharing Limits: Out-of-pocket costs (like deductibles or copays) for fertility treatments cannot exceed those for similar medical services; plans can offer better terms but not worse. The Secretary must issue quick regulations to enforce this.
- Prohibitions on Interference:
- Plans cannot offer incentives to discourage patients or providers from using fertility treatments.
- Providers cannot be penalized for discussing or providing these services.
- No discrimination based on race, sex, age, disability, or other protected categories under civil rights laws (e.g., Civil Rights Act of 1964).
- Notice Requirements: Plans must inform enrollees about this coverage in writing, prominently in materials, starting by January 1, 2027, or earlier, and annually thereafter.
- Flexibility: Patients cannot be forced to undergo treatment; plans can still negotiate payment rates with providers.
- Government Program Extensions:
- Federal Employees: Adds coverage to the Federal Employees Health Benefits Program, with cost-sharing matching obstetrical benefits.
- Military (TRICARE): Requires coverage consistent with private plans, with the Secretary of Defense setting cost-sharing rules.
- Veterans Affairs (VA): Provides fertility treatments to veterans and their spouses/partners upon joint application.
- Medicaid: States must cover fertility treatments as part of family planning services, effective October 1, 2026 (with a delay if state laws need updating).
- Medicare: Covers fertility treatments starting January 1, 2026, with no deductible or coinsurance (full payment up to the standard rate), treating it like other preventive services.
- Effective Dates: Generally 6 months after enactment for private plans (with exceptions for union-negotiated plans); specific dates for government programs.
Significant Changes to Existing Law
- Expands essential health benefits under the Affordable Care Act (ACA) by adding fertility coverage as a new standard, similar to how it mandated maternity care.
- Introduces parity (equal treatment) in cost-sharing for fertility services, which were previously often excluded or limited in many plans.
- For the first time, mandates fertility coverage in Medicare (typically for seniors, but applicable here for age-related or other fertility issues) and VA programs, going beyond current family planning rules in Medicaid.
- Allows expedited regulations without usual public comment periods to speed implementation.
- No changes to self-insured plans' exemptions, but ERISA amendments ensure broader application.
Potential Impacts
- On Citizens: Improves access to costly fertility care (e.g., IVF can cost $12,000–$15,000 per cycle) for millions with insurance, reducing financial barriers for those facing infertility, delayed parenthood, or medical issues affecting fertility. Could increase birth rates among insured populations but may raise premiums slightly for all.
- On Government Agencies: Increases costs for federal programs (Medicare, Medicaid, VA, TRICARE, federal employee plans), potentially requiring budget adjustments; states may need to update Medicaid plans, with federal funding covering most costs.
- On Health Insurers and Employers: Mandates new benefits, possibly increasing administrative burdens and premiums (estimated 1–2% rise per some studies on similar mandates), but allows negotiation of provider payments to control costs.
- International Relations: Minimal direct impact, though it aligns U.S. policy with global trends in reproductive health access (e.g., in Europe), potentially influencing aid or diplomacy on family planning.
Main Stakeholders Affected
- Individuals and Families: Primary beneficiaries, especially those aged 25–44 dealing with infertility (affecting ~10–15% of couples), LGBTQ+ individuals, single parents, or those with medical conditions.
- Health Insurers and Providers: Insurers must comply and cover costs; fertility clinics and doctors gain more patients but face reimbursement negotiations.
- Employers: Sponsors of group plans may see higher costs, particularly small businesses, though large ones often already offer some benefits.
- Government Entities: Departments of Health and Human Services, Defense, and Veterans Affairs must implement and regulate; states handle Medicaid expansions.
- Advocacy Groups: Organizations like Resolve (fertility advocacy) support it; opponents may include fiscal conservatives concerned about costs.
Notable Legal, Constitutional, or Political Implications
- Legal: Strengthens anti-discrimination protections by tying fertility coverage to existing civil rights laws, potentially reducing lawsuits over unequal access. The broad definition of fertility treatment could lead to challenges over what qualifies as "appropriate" care, with courts likely deferring to federal agencies.
- Constitutional: No major issues anticipated, as it regulates commerce (health insurance) under Congress's powers and expands benefits without infringing on privacy rights (e.g., Roe v. Wade precedents on reproductive choice, though post-Dobbs landscape may spark state-level pushback). The opt-out for patients preserves autonomy.
- Political: Advances reproductive health equity, appealing to progressive priorities, but could face opposition over federal overreach and costs (estimated $1–2 billion annually for government programs). May influence elections in states with varying fertility laws; builds on ACA expansions, risking partisan divides.
This summary was generated by AI and may contain inaccuracies. Refer to the official source document for the authoritative text.
Sponsor
Cosponsors (6)
Sen. Schumer, Charles E. [D-NY], Sen. Duckworth, Tammy [D-IL], Sen. Murray, Patty [D-WA], Sen. Coons, Christopher A. [D-DE], Sen. Klobuchar, Amy [D-MN], Sen. Welch, Peter [D-VT]
Recent Actions
- 2025-07-23: Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
- 2025-07-23: Introduced in Senate
Bill Versions
- Access to Fertility Treatment and Care Act — issued 2025-07-23 — PDF (24 pages)